Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmacy Groups Exploring Medicare Rx Fallback Options

Executive Summary

The retail pharmacy trade associations hope to reach an agreement on a fallback Medicare drug benefit proposal with a group of pharmaceutical manufacturers over the next month

You may also be interested in...



Retail Pharmacy Answer To PBMs In Medicare Rx Debate: “PBAs”

Rep. Jo Ann Emerson's (R-Mo.) Medicare drug discount card/catastrophic coverage bill would rely on a "PBA" (pharmacy benefit administrator) rather than a PBM to process the benefit

Retail Pharmacy Answer To PBMs In Medicare Rx Debate: “PBAs”

Rep. Jo Ann Emerson's (R-Mo.) Medicare drug discount card/catastrophic coverage bill would rely on a "PBA" (pharmacy benefit administrator) rather than a PBM to process the benefit

Rx Cost Impact On Medicare Patient Drug Use To Be Studied By AHRQ

The Agency for Healthcare Research & Quality is proposing to study the financial barriers to filling and correctly using prescriptions in the Medicare population

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel